Phenserine
Phenserine ((-) -Eseroline phenylcarbamate) is a derivative of Physostigmine and is a potent, noncompetitive, long-acting and selective AChE inhibitor. Phenserine reduces β-amyloid precursor protein (APP) and β-amyloid peptide (Aβ) formation. Phenserine improves cognitive performance and attenuates the progression of Alzheimer's disease[1][2][3].
Product Specifications
CAS Number
101246-66-6
Product Name Alternative
(-) -Eseroline phenylcarbamate; (-) -Phenserine
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
Amyloid-β; Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/phenserine.html
Purity
99.55
Solubility
DMSO : 200 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CN1[C@](N(C)CC2)([H])[C@]2(C)C3=C1C=CC(OC(NC4=CC=CC=C4)=O)=C3
Molecular Formula
C20H23N3O2
Molecular Weight
337.42
Precautions
H315, H319, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Isoform
AChE
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HMGN5, NT (HMGN5, NSBP1, High mobility group nucleosome-binding domain-containing protein 5, Nucleosome-binding protein 1) (MaxLight 750) discontinued
